AGRYX Performance — AB Growth Fund, Advisor Class
Data updated: 2026-09-09
AGRYX returned +5.79% year to date and +11.08% over one year to Jun 2026. Annualised returns are +19.76% over 3 years and +10.49% over 5 years. The fund trailed its US Large Growth category average: $100 invested three years ago grew to $172, against $175 for the category, and to $111 over one year, against $117. Volatility over the past three years was 17.08% a year. In the 12 months to Jun 2026 the fund took in a net $25.6M, and assets reached $1.55B.
AGRYX Growth of $100
What $100 invested in AB Growth Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Growth category average over the same months.
| Period | AGRYX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $111 | $117 |
| 3 years (Jul 2023 – Jun 2026) | $172 | $175 |
| 5 years (Jul 2021 – Jun 2026) | $165 | $166 |
| Since data start (Aug 2019 – Jun 2026) | $264 | $268 |
AGRYX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.79% |
| 1 year | +11.08% |
| 3 years (annualised) | +19.76% |
| 5 years (annualised) | +10.49% |
AGRYX Annual Returns
Calendar-year total returns of AB Growth Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +5.79% |
| 2025 | +11.15% |
| 2024 | +32.01% |
| 2023 | +37.86% |
| 2022 | −29.47% |
| 2021 | +21.38% |
| 2020 | +36.27% |
| 2019 (Aug–Dec) | +5.67% |
AGRYX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.6% | −2.5% | −6.6% | +14.3% | +4.6% | −2.2% | — | — | — | — | — | — |
| 2025 | +4.1% | −5.0% | −7.9% | +2.0% | +7.6% | +5.9% | +2.3% | +0.2% | +3.4% | +1.5% | −1.3% | −1.1% |
| 2024 | +4.0% | +8.2% | +2.2% | −6.2% | +6.4% | +5.1% | −3.1% | +1.9% | +2.5% | +1.2% | +7.9% | −1.0% |
| 2023 | +8.6% | −2.4% | +6.2% | +1.8% | +3.5% | +5.1% | +2.7% | −0.8% | −5.3% | −1.0% | +10.1% | +5.3% |
| 2022 | −9.9% | −4.3% | +1.4% | −11.2% | −2.5% | −6.9% | +10.9% | −6.1% | −9.0% | +5.6% | +7.4% | −6.9% |
| 2021 | −2.6% | +1.0% | +1.3% | +7.5% | −1.0% | +4.9% | +4.3% | +2.3% | −7.0% | +6.5% | −0.1% | +3.3% |
| 2020 | +0.8% | −5.9% | −10.5% | +15.2% | +10.0% | +2.0% | +6.6% | +6.1% | −3.4% | −1.1% | +10.3% | +4.2% |
| 2019 | — | — | — | — | — | — | — | −0.8% | −1.1% | +1.9% | +3.3% | +2.2% |
AGRYX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 17.08%
- 3-year Sharpe ratio: 0.89 (vs 4.5% risk-free rate)
- Best month: +14.26% (Apr 2026)
- Worst month: −7.88% (Mar 2025)
AGRYX Fund Flows
Monthly money in and out of AB Growth Fund, from SEC Form N-PORT.
- 12-month net flow: $25.6M
- 12-month gross sales (incl. reinvestments): $264.2M
- Sales ÷ redemptions: 1.11×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $4.6M | $23.7M | −$19.1M |
| May 2026 | $4.4M | $22.7M | −$18.3M |
| Apr 2026 | $3.1M | $21.1M | −$18.0M |
| Mar 2026 | $6.5M | $28.2M | −$21.7M |
| Feb 2026 | $6.0M | $18.8M | −$12.8M |
| Jan 2026 | $8.5M | $16.3M | −$7.8M |
| Dec 2025 | $197.5M | $19.2M | $178.4M |
| Nov 2025 | $4.8M | $17.6M | −$12.7M |
| Oct 2025 | $7.7M | $19.0M | −$11.2M |
| Sep 2025 | $9.5M | $17.0M | −$7.5M |
| Aug 2025 | $4.7M | $16.1M | −$11.4M |
| Jul 2025 | $6.9M | $18.9M | −$12.1M |
AGRYX Assets Under Management
Net assets of AB Growth Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.55B |
| 2026-04-30 | $1.55B |
| 2026-01-31 | $1.55B |
| 2025-10-31 | $1.66B |
| 2025-07-31 | $1.60B |
| 2025-04-30 | $1.41B |
| 2025-01-31 | $1.61B |
| 2024-10-31 | $1.50B |
| 2024-07-31 | $1.46B |
| 2024-04-30 | $1.38B |
| 2024-01-31 | $1.36B |
| 2023-10-31 | $1.15B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.